More data, this time from a large observational study, are bolstering the idea that glucagon-like peptide-1 (GLP-1) receptor ...

The technology, which led to a shift in strategy more than half of the time, could save $719 per symptomatic patient over 10 years.

The predicted risks didn’t align well with actual events, raising questions about how well the tool will fare if rolled out.

Half of male cyclists had some myocardial scarring, but experts caution against taking this to mean too much exercise is ...

“Sudden cardiac death is the leading cause of death in firefighters nationally, and it accounts for 40% of all line-of-duty ...

Implementation strategies are now needed to get polypills into the hands of more patients, particularly in poorer countries.

The study isn’t intended to sway clinical decision-making, but to make doctors aware of the impact of their choices.

A patient forum identified the desire for better, earlier education as well as the toll on independence TR takes as it ...

Patients whose hypertension diagnosis is delayed are less likely to get the drugs they need and face higher CV risks over the ...

The frequent exclusion of such patients from trials makes real-world data like these valuable for clinicians, says Eric ...

The BaxHTN study met its primary endpoint, and researchers will present more data at the ESC Congress later this summer.